A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial

被引：8
|
作者：
Y. Kanno
M. Witt
H. Okada
H. Nemoto
S. Sugahara
H. Nakamoto
H. Suzuki
机构：
[1] Department of Nephrology,
[2] Saitama Medical School,undefined
[3] 38 Morohongo,undefined
[4] Moroyama-machi,undefined
[5] Iruma-gun,undefined
[6] Saitama 350-0495,undefined
[7] JapanvTel. +81-492-76-1611; Fax +81-492-95-7338 e-mail: iromichi@saitama-med.ac.jp.,undefined
来源：
Clinical and Experimental Nephrology | 2003年 / 7卷 / 1期
关键词：
Key words IgA nephropathy; Warfarin; Corticosteroid;
D O I：
10.1007/s101570300006
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：0048 / 0051
页数：3
相关论文
共 50 条
  • [21] Corticosteroid therapy in patients with IgA nephropathy and impaired renal function
    Tamura, S
    Ueki, K
    Ideura, H
    Tsukada, Y
    Maezawa, A
    Kawai, H
    Wakamatsu, R
    Yano, S
    Nojima, Y
    Naruse, T
    CLINICAL NEPHROLOGY, 2001, 55 (03) : 192 - 195
  • [22] Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation
    Tang, Zheng
    Ji, Shu-Ming
    Chen, Dong-Rui
    Wen, Ji-Qiu
    Chen, Jin-Song
    Liu, Zhi-Hong
    Li, Lei-Shi
    RENAL FAILURE, 2008, 30 (06) : 611 - 616
  • [23] EARLY CORTICOSTEROID TREATMENT IN CHILDREN WITH IGA NEPHROPATHY: A RANDOMIZED AND CONTROLLED TRIAL
    Nuzzi, F.
    D'Armiento, M.
    Malgieri, G.
    Ferretti, A.
    Marzano, L.
    Pecoraro, C.
    PEDIATRIC NEPHROLOGY, 2009, 24 (09) : 1781 - 1781
  • [24] CONTROLLED TRIAL OF PHENYTOIN THERAPY IN IGA NEPHROPATHY
    CLARKSON, AR
    SEYMOUR, AE
    WOODROFFE, AJ
    MCKENZIE, PE
    CHAN, YL
    WOOTTON, AM
    CLINICAL NEPHROLOGY, 1980, 13 (05) : 215 - 218
  • [25] CONTROLLED TRIAL OF PHENYTOIN THERAPY IN IGA NEPHROPATHY
    CLARKSON, AR
    SEYMOUR, AE
    WOODROFFE, AJ
    MCKENZIE, PE
    CHAN, YL
    WOOTTON, AM
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1980, 10 (01): : 125 - 125
  • [26] Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy
    Min, Lulin
    Wang, Qin
    Cao, Liou
    Zhou, Wenyan
    Yuan, Jiangzi
    Zhang, Minfang
    Che, Xiajing
    Mou, Shan
    Fang, Wei
    Gu, Leyi
    Zhu, Mingli
    Wang, Ling
    Yu, Zanzhe
    Qian, Jiaqi
    Ni, Zhaohui
    ONCOTARGET, 2017, 8 (29) : 48375 - 48384
  • [27] Renoprotective therapy and corticosteroids in IgA nephropathy: preliminary observations
    Kim, M. J.
    Giannini, O.
    Mihatsch, M. J.
    Steiger, J.
    Mayr, M.
    SWISS MEDICAL WEEKLY, 2007, 137 : S16 - S16
  • [28] Prospective trial of combined therapy with Heparin/Warfarin and renin-angiotensin system inhibitors in progressive IgA nephropathy
    Ishii, Takeo
    Kawamura, Tetsuya
    Tsuboi, Nobuo
    Ogura, Makoto
    Utsunomiya, Yasunori
    Hosoya, Tatsuo
    IGA NEPHROPATHY TODAY, 2007, 157 : 114 - 119
  • [29] Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT
    Shima, Yuko
    Nakanishi, Koichi
    Kaku, Yoshitsugu
    Ishikura, Kenji
    Hataya, Hiroshi
    Matsuyama, Takeshi
    Honda, Masataka
    Sako, Mayumi
    Nozu, Kandai
    Tanaka, Ryojiro
    Iijima, Kazumoto
    Yoshikawa, Norishige
    PEDIATRIC NEPHROLOGY, 2018, 33 (11) : 2103 - 2112
  • [30] Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT
    Yuko Shima
    Koichi Nakanishi
    Yoshitsugu Kaku
    Kenji Ishikura
    Hiroshi Hataya
    Takeshi Matsuyama
    Masataka Honda
    Mayumi Sako
    Kandai Nozu
    Ryojiro Tanaka
    Kazumoto Iijima
    Norishige Yoshikawa
    Pediatric Nephrology, 2018, 33 : 2103 - 2112
12345